Alzheimer disease causes up to 80% of dementia cases, and slowing its progression is the most promising treatment option to date. However, the early identification of high-risk patients remains a considerable challenge. This episode presents three relevant advances in artificial intelligence (AI) that can help detect symptoms at preclinical stages.

References

1. Jang H, Soroski T, Rizzo M, Barral O, Harisinghani A, Newton-Mason S, et al. Classification of Alzheimer's Disease Leveraging Multi-task Machine Learning Analysis of Speech and Eye-Movement Data. Front Hum Neurosci. [Internet] 2021. (Accessed on June 11, 2022);15:716670. Available at: https://www.frontiersin.org/articles/10.3389/fnhum.2021.716670/full
2. Grueso S, Viejo-Sobera R. Machine learning methods for predicting progression from mild cognitive impairment to Alzheimer's disease dementia: a systematic review. Alzheimers Res Ther. [Internet] 2021. (Accessed on June 11, 2022);13(1):162. Available at: https://alzres.biomedcentral.com/articles/10.1186/s13195-021-00900-w
3. James C, Ranson JM, Everson R, Llewellyn DJ. Performance of Machine Learning Algorithms for Predicting Progression to Dementia in Memory Clinic Patients. JAMA Netw Open. [Internet] 2021. (Accessed on June 11, 2022);4(12):e2136553. Available at: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2787228

NON-2023-3467